Abstract
Scedosporium aurantiacum is one of the emergent opportunistic fungal pathogens among immunocompromised hosts. Colonization of S. aurantiacum can also occur in patients with underlying lung diseases such as cystic fibrosis. S. aurantiacum is highly resistant to multiple antifungal agents, and management of the infected patients can be very challenging compared to those infected with other species of Scedosporium. Clinical cases have been geographically restricted mostly in Australia with a small number of cases identified in Europe and Japan. Although clinical isolates of S. aurantiacum from the USA have been included in several research studies, no clinical case of S. aurantiacum infection from the USA has been described. We report a case of S. aurantiacum infection acquired in the SA. Awareness of S. aurantiacum among healthcare providers and the species-level identification for Scedosporium are critically important for appropriate selection of antifungal agents and improvement of treatment outcomes.
Similar content being viewed by others
References
Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008;21:157–97.
Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F, et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis–a review. Med Mycol. 2009;47:387–97.
Harun A, Serena C, Gilgado F, Chen SC-A, Meyer W. Scedosporium aurantiacum is as virulent as S. prolificans, and shows strain-specific virulence differences, in a mouse model. Med Mycol. Oxford Academic; 2010;48:S45–51.
Wiederhold NP, Law D, Birch M. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans. J Antimicrob Chemother Oxford Academic. 2017;72:1977–80.
Chen M, Zeng J, DeHoog GS, Stielow B, Gerrits Van Den Ende AHG, Liao W, et al. The ‘species complex’ issue in clinically relevant fungi: A case study in Scedosporium apiospermum. Fungal Biol. 2016;120:137–46.
Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Clinical Laboratory Standards Institute, M38 3rd Edition, 2017.
Lackner M, de Hoog GS, Yang L, Ferreira Moreno L, Ahmed SA, Andreas F, et al. Proposed nomenclature for pseudallescheria. Scedosporium Relat Gen Fung Div. 2014;67:1–10.
Gilgado F, Cano J, Gené J, Guarro J. Molecular phylogeny of the pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol. 2005;43:4930–42.
Gilgado F, Serena C, Cano J, Gené J, Guarro J. Antifungal susceptibilities of the species of the pseudallescheria boydii complex. Antimicrob Agents Chemother. 2006;50:4211–3.
Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, et al. Species-specific antifungal susceptibility patterns of scedosporium and pseudallescheria species. Antimicrob Agents Chemother. 2012;56:2635–42.
Perfect JR. Treatment of non-aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis. 2005;40:S401–8.
Nakamura Y, Suzuki N, Nakajima Y, Utsumi Y, Murata O, Nagashima H, et al. Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan. Respir Investig. 2013;51:207–11.
Acknowledgments
We would like to thank staff working in the Mycology Laboratory at the Johns Hopkins Hospital for their technical support for this case study.
Funding
None.
Author information
Authors and Affiliations
Contributions
SZ and MM contributed to conceptualization. The first draft of the manuscript was written by MM. Sequencing analyses were performed by MT. All authors contributed to writing, reviewing and editing of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of intersts
The authors declare that they have no conflict of interest.
Additional information
Handling Editor: Vishnu Chaturvedi.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mizusawa, M., Totten, M. & Zhang, S.X. A Case of Scedosporium aurantiacum Infection in the United States. Mycopathologia 186, 127–130 (2021). https://doi.org/10.1007/s11046-020-00498-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-020-00498-x